Inovio Pharmaceuticals, Inc. (INO)
1.73
-0.56
(-24.45%)
USD |
NASDAQ |
Dec 29, 16:00
1.72
-0.01
(-0.58%)
Pre-Market: 08:04
Inovio Pharmaceuticals Total Liabilities (Quarterly): 77.11M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 514.76M |
| Perspective Therapeutics, Inc. | 52.61M |
| Arcturus Therapeutics Holdings, Inc. | 57.78M |
| Capricor Therapeutics, Inc. | 42.57M |
| Myomo, Inc. | 19.45M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 69.39M |
| Shareholders Equity (Quarterly) | -7.72M |
| Debt to Equity Ratio | -1.298 |
| Current Ratio | 0.7903 |
| Net Debt Paydown Yield | 0.47% |